Search Results - "ENETS CONSENSUS GUIDELINES"
-
1
Authors: et al.
Source: Front Endocrinol (Lausanne)
Frontiers in Endocrinology, Vol 16 (2025)Subject Terms: peptide receptor radionuclide therapy, PROGNOSIS, DIAGNOSIS, RC648-665, ENETS CONSENSUS GUIDELINES, TUMORS, LU-177-DOTATATE, TOXICITY, Diseases of the endocrine glands. Clinical endocrinology, pedictict overall survival, machine learning, Endocrinology, clinical decision support nomogram, SURVIVAL, MANAGEMENT, pancreatic neuroendocrine neoplasm, FOLLOW-UP, STANDARDS
-
2
Authors: et al.
Contributors: et al.
Source: DIGESTIVE AND LIVER DISEASE
Subject Terms: Hypoglicemia, SURGERY, INTERNATIONAL STUDY-GROUP, ENETS CONSENSUS GUIDELINES, CLASSIFICATION, Endosonography, Neuroendocrine tumor, Medicine and Health Sciences, MANAGEMENT, Insulin, Humans, Multicenter Studies as Topic, Acute pancreatiti, Randomized Controlled Trials as Topic, COMPLICATIONS, Radiofrequency Ablation, Endoscopic ultrasound, 3. Good health, Acute pancreatitis, Pancreatic Neoplasms, DEFINITION, Quality of Life, Insulinoma, Neuroendocrine tumors, ADVERSE EVENTS, acute pancreatitis, endoscopic ultrasound, hypoglicemia, insulin, neuroendocrine tumors, pancreatic fistula, NEUROENDOCRINE TUMORS, Pancreatic fistula, NEOPLASMS
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/37407318
https://www.sciencedirect.com/science/article/pii/S1590865823007193?via=ihub
https://hdl.handle.net/20.500.11768/148557
https://doi.org/10.1016/j.dld.2023.06.021
https://hdl.handle.net/11562/1108786
https://doi.org/10.1016/j.dld.2023.06.021
https://hdl.handle.net/11573/1684704
https://doi.org/10.1016/j.dld.2023.06.021
https://biblio.ugent.be/publication/01J0V17NY48PX2JV7ZTYWAF7YT/file/01J0V1CSPMT2FCMG07G7PEBA6N
http://doi.org/10.1016/j.dld.2023.06.021
https://biblio.ugent.be/publication/01J0V17NY48PX2JV7ZTYWAF7YT
http://hdl.handle.net/1854/LU-01J0V17NY48PX2JV7ZTYWAF7YT -
3
Authors: et al.
Contributors: et al.
Source: Eurasian Journal of Medicine and Oncology
Subject Terms: Prognostic-Factors, Survival, Efficacy, Epidemiology, High-Grade, radiolabeled somatostatin analogues, Peptide receptor radionuclide therapy, G3, Tyr(3) Octreotate, Enets Consensus Guidelines, peptide receptor radionuclide therapy, Lu-177-Dotatate, neuroendocrine neoplasm, general and internal, 3. Good health, Peptide Receptor Radionuclide Therapy, Neuroendocrine neoplasm, Lutetium-177, Neuroendocrine tumors, PRRT, Radiolabeled somatostatin analogues, Neuroendocrine Tumors, Oncology, Medicine, general and internal, Radiolabeled Somatostatin Analogues, Medicine, Neuroendocrine Neoplasm, neuroendocrine tumors
File Description: pdf; application/pdf
Access URL: https://avesis.kocaeli.edu.tr/publication/details/49b5bdea-b5d9-485e-a0bd-776bcbf457e3/oai
https://avesis.gazi.edu.tr/publication/details/49b5bdea-b5d9-485e-a0bd-776bcbf457e3/oai
http://cdm21054.contentdm.oclc.org/cdm/ref/collection/IR/id/11317
https://hdl.handle.net/11468/13209
https://www.scopus.com/record/display.uri?eid=2-s2.0-85175379046&origin=resultslist&sort -
4
Authors: et al.
Source: Poleé, I N, Hermans, B C M, van der Zwan, J M, Bouwense, S A W, Dercksen, M W, Eskens, F A L M, Havekes, B, Hofland, J, Kerkhofs, T M A, Klümpen, H-J, Latten-Jansen, L M, Speel, E-J M, Verburg, F A, Walenkamp, A M E, Geurts, S M E & de Vos-Geelen, J 2022, 'Long-term survival in patients with gastroenteropancreatic neuroendocrine neoplasms : A population-based study', European Journal of Cancer, vol. 172, pp. 252-263. https://doi.org/10.1016/j.ejca.2022.06.003
Subject Terms: Gastrointestinal, Survival, Population-based, ENETS CONSENSUS GUIDELINES, 03 medical and health sciences, EVEROLIMUS, PROGNOSTIC-FACTORS, 0302 clinical medicine, Neuroendocrine tumours, SDG 3 - Good Health and Well-being, Stomach Neoplasms, Intestinal Neoplasms, MANAGEMENT, EPIDEMIOLOGY, Humans, Pancreas, OUTCOMES, Prognosis, CANCER, TUMORS, Carcinoid, 3. Good health, Pancreatic Neoplasms, Neuroendocrine Tumors, RISK-FACTORS, EXPERIENCE
-
5
Authors: et al.
Source: Endosc Int Open
Endoscopy International Open, Vol 10, Iss 07, Pp E940-E951 (2022)Subject Terms: RC799-869, Diseases of the digestive system. Gastroenterology, ENETS CONSENSUS GUIDELINES, TUMORS, CLASSIFICATION, 3. Good health, 03 medical and health sciences, GRADE, 0302 clinical medicine, COLON, RECTAL CARCINOIDS, MANAGEMENT, RISK-FACTORS, UPDATE
-
6
Authors: et al.
Source: Endocrine-Related Cancer. 28:549-561
Subject Terms: 0301 basic medicine, grade 3, treatment, CARCINOMA, NEN, CHEMOTHERAPY, Adenocarcinoma, ENETS CONSENSUS GUIDELINES, 3. Good health, G3, Pancreatic Neoplasms, Neuroendocrine Tumors, 03 medical and health sciences, Treatment Outcome, 0302 clinical medicine, Humans, prognosis, neuroendocrine tumors, PREDICTORS, Somatostatin, GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS, NEOPLASMS, Etoposide, Platinum, Retrospective Studies
Access URL: https://pubmed.ncbi.nlm.nih.gov/34061764
https://pubmed.ncbi.nlm.nih.gov/34061764/
https://www.ncbi.nlm.nih.gov/pubmed/34061764
https://christie.aws.openrepository.com/handle/10541/624103
https://europepmc.org/article/MED/34061764
https://christie.openrepository.com/handle/10541/624103
https://erc.bioscientifica.com/view/journals/erc/28/8/ERC-21-0109.xml -
7
Authors: et al.
Contributors: et al.
Source: Acta Oncologica
Janson, E T, Knigge, U, Dam, G, Federspiel, B, Grønbaek, H, Stålberg, P, Langer, S W, Kjaer, A, Arola, J, Schalin-Jäntti, C, Sundin, A, Welin, S, Thiis-Evensen, E & Sorbye, H 2021, 'Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms', Acta Oncologica, vol. 60, no. 7, pp. 931-941. https://doi.org/10.1080/0284186X.2021.1921262
Janson, E T, Knigge, U, Dam, G, Federspiel, B, Grønbaek, H, Stålberg, P, Langer, S W, Kjaer, A, Arola, J, Schalin-Jäntti, C, Sundin, A, Welin, S, Thiis-Evensen, E & Sorbye, H 2021, ' Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms ', Acta Oncologica, vol. 60, no. 7, pp. 931-941 . https://doi.org/10.1080/0284186X.2021.1921262Subject Terms: 0301 basic medicine, SURGERY, Neuroendocrine Tumors/diagnosis, Endocrinology and Diabetes, CHROMOGRANIN-A, ENETS CONSENSUS GUIDELINES, LIVER METASTASES, G3, 03 medical and health sciences, PROGNOSTIC-FACTORS, 0302 clinical medicine, Stomach Neoplasms, Stomach Neoplasms/diagnosis, Diagnosis, Intestinal Neoplasms, neuroendocrine tumour, Intestinal Neoplasms/diagnosis, Humans, Pancreatic Neoplasms/diagnosis, Gastrointestinal Neoplasms, Cancer och onkologi, treatment, neuroendocrine carcinoma, CHEMOTHERAPY, GA-68-DOTATOC, TUMORS, General medicine, internal medicine and other clinical medicine, 3. Good health, Pancreatic Neoplasms, Neuroendocrine Tumors, Cancer and Oncology, CARCINOMAS, Endokrinologi och diabetes, Cancers
File Description: application/pdf
Access URL: https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2021.1921262?needAccess=true
https://pubmed.ncbi.nlm.nih.gov/33999752
https://europepmc.org/article/MED/33999752
https://pubmed.ncbi.nlm.nih.gov/33999752/
https://www.ncbi.nlm.nih.gov/pubmed/33999752
https://www.tandfonline.com/doi/full/10.1080/0284186X.2021.1921262
https://helda.helsinki.fi/handle/10138/336180
https://hdl.handle.net/11250/2991924
http://hdl.handle.net/10138/336180
https://pure.au.dk/portal/en/publications/bddf8218-23bc-4182-80bd-0e3b9c4e8d1c
https://curis.ku.dk/ws/files/275434358/Nordic_guidelines_2021_for_diagnosis_and.pdf
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-454175
https://pure.au.dk/portal/en/publications/bddf8218-23bc-4182-80bd-0e3b9c4e8d1c
https://pure.au.dk/ws/files/274448249/Nordic_guidelines_2021_for_diagnosis_and_treatment_of_gastroenteropancreatic_neuroendocrine_neoplasms.pdf
https://doi.org/10.1080/0284186X.2021.1921262 -
8
Authors: et al.
Contributors: et al.
Source: Clinical Endocrinology. 94:250-257
Subject Terms: Adult, insulin, Delayed Diagnosis, SURGERY, QUESTIONNAIRE, hyperinsulinism, insulinoma, PITUITARY-ADENOMAS, 3121 Internal medicine, SURGICAL COMPLICATIONS, ENETS CONSENSUS GUIDELINES, CLASSIFICATION, 03 medical and health sciences, 0302 clinical medicine, Surveys and Questionnaires, MANAGEMENT, Humans, pancreas, RECURRENCE, Finland, ta3121, ta3122, General medicine, internal medicine and other clinical medicine, 3. Good health, quality of life, Quality of Life, Insulinoma, neuroendocrine tumors, NEUROENDOCRINE TUMORS, hypoglycaemia
File Description: application/pdf; fulltext
Access URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cen.14336
https://pubmed.ncbi.nlm.nih.gov/32974918
http://juuli.fi/Record/0371827220
https://doi.org/10.1111/cen.14336
http://juuli.fi/Record/0387716821
https://europepmc.org/article/MED/32974918
https://onlinelibrary.wiley.com/doi/full/10.1111/cen.14336
https://researchportal.helsinki.fi/fi/publications/long-term-health-related-quality-of-life-in-persons-diagnosed-wit
https://www.ncbi.nlm.nih.gov/pubmed/32974918
https://pubmed.ncbi.nlm.nih.gov/32974918/
https://onlinelibrary.wiley.com/doi/pdf/10.1111/cen.14336
http://hdl.handle.net/10138/325995
http://urn.fi/urn:nbn:fi-fe202102235739
https://trepo.tuni.fi/handle/10024/127691 -
9
Authors: et al.
Source: Neuroendocrinology. 111:1111-1120
Subject Terms: Male, Lung Neoplasms, Survival, CARCINOMA, Bone Neoplasms, Metastases, ENETS CONSENSUS GUIDELINES, Cohort Studies, 03 medical and health sciences, PROGNOSTIC-FACTORS, 0302 clinical medicine, SDG 3 - Good Health and Well-being, Humans, Registries, Neoplasm Metastasis, Gastroenteropancreatic neuroendocrine tumors, Stage IV, Lung, Aged, Netherlands, BONE METASTASES, Brain Neoplasms, Liver Neoplasms, Brain, CHEMOTHERAPY, Middle Aged, Carcinoid, TUMORS, 3. Good health, Neuroendocrine Tumors, RISK-FACTORS, SURVIVAL, UPDATE, Female, LUNG
Access URL: https://www.karger.com/Article/Pdf/513249
https://pubmed.ncbi.nlm.nih.gov/33227805
https://pure.eur.nl/en/publications/e0a850fa-7c34-47b7-b544-8206c6271f87
https://doi.org/10.1159/000513249
https://cris.maastrichtuniversity.nl/en/publications/d70a406d-33ec-4106-85c5-1e2f05030580
https://doi.org/10.1159/000513249
https://pubmed.ncbi.nlm.nih.gov/33227805/
https://www.ncbi.nlm.nih.gov/pubmed/33227805
http://www.ncbi.nlm.nih.gov/pubmed/33227805
https://cris.maastrichtuniversity.nl/en/publications/unique-metastatic-patterns-in-neuroendocrine-neoplasms-of-differe-2 -
10
Authors: et al.
Contributors: et al.
Source: Sluiter, N R, van der Bilt, J D, Croll, D M R, Vriens, M R, de Hingh, I H J T, Hemmer, P, Aalbers, A G J, Bremers, A J A, Ceelen, W, D'Hoore, A, Schoonmade, L J, Coupé, V, Verheul, H, Kazemier, G & Tuynman, J B 2020, 'Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Versus Surgery Without HIPEC for Goblet-Cell Carcinoids and Mixed Adenoneuroendocrine Carcinomas : Propensity Score–Matched Analysis of Centers in the Netherlands and Belgium', Clinical Colorectal Cancer, vol. 19, no. 3, pp. e87-e99. https://doi.org/10.1016/j.clcc.2020.01.002
Clinical Colorectal Cancer, 19, 3, pp. e87-e99Subject Terms: Adult, Male, Databases, Factual, Datasets as Topic, Carcinoid Tumor, Hyperthermic Intraperitoneal Chemotherapy, Adenocarcinoma, ENETS CONSENSUS GUIDELINES, PATIENT SELECTION, CLASSIFICATION, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, Belgium, MANAGEMENT, Humans, Cytoreductive surgery, Prospective Studies, Medical Oncology - Radboud University Medical Center, Propensity Score, Peritoneal Neoplasms, Aged, Gastrointestinal Neoplasms, Netherlands, Gastroenterology, COLORECTAL PERITONEAL METASTASES, Cytoreduction Surgical Procedures, Middle Aged, Radboudumc 14: Tumours of the digestive tract RIHS: Radboud Institute for Health Sciences, Colorectal cancer, RANDOMIZED-TRIAL, Gastrointestinal neoplasm, 3. Good health, Neuroendocrine Tumors, Peritoneal metastases, Oncology, SURVIVAL, SYSTEMIC CHEMOTHERAPY, Female, NEUROENDOCRINE TUMORS, Radboudumc 10: Reconstructive and regenerative medicine RIHS: Radboud Institute for Health Sciences, Surgery - Radboud University Medical Center, NEOPLASMS
File Description: application/pdf
Access URL: https://pure.rug.nl/ws/files/157617327/1_s2.0_S1533002820300025_main.pdf
https://pubmed.ncbi.nlm.nih.gov/32651131
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/226019
https://doi.org/10.1016/j.clcc.2020.01.002
https://hdl.handle.net/11370/4a4b8ec5-c611-44c6-8674-dad4c9b492ba
https://research.rug.nl/en/publications/4a4b8ec5-c611-44c6-8674-dad4c9b492ba
https://doi.org/10.1016/j.clcc.2020.01.002
https://repository.ubn.ru.nl/handle/2066/226019
https://www.sciencedirect.com/science/article/pii/S1533002820300025
http://www.sciencedirect.com/science/article/pii/S1533002820300025
https://www.ncbi.nlm.nih.gov/pubmed/32651131
https://www.narcis.nl/publication/RecordID/oai%3Arepository.ubn.ru.nl%3A2066%2F226019
https://research.vumc.nl/en/publications/cytoreduction-and-hyperthermic-intraperitoneal-chemotherapy-hipec
https://research.vumc.nl/en/publications/ea4a5b3d-6195-42fe-a2b1-0844885e8002
https://dspace.library.uu.nl/handle/1874/441353
https://hdl.handle.net/2066/226019
https://repository.ubn.ru.nl//bitstream/handle/2066/226019/226019.pdf -
11
Authors: et al.
Source: Ann Nucl Med
Subject Terms: Male, Single Photon Emission Computed Tomography Computed Tomography, RECEPTOR RADIONUCLIDE THERAPY, ENETS CONSENSUS GUIDELINES, CHROMOGRANIN-A, RESPONSE EVALUATION, PROGNOSTIC-FACTORS, TYR(3) OCTREOTATE, PEPTIDE, LU-177, NEOPLASMS, MIDGUT, Monte Carlo simulations, Dosimetry, Lu-177-DOTATOC, Neuroendocrine tumors, Antineoplastic Agents, Lutetium, Octreotide, 03 medical and health sciences, 0302 clinical medicine, Organometallic Compounds, Humans, 570 Biowissenschaften, Biologie, ddc:610, Radiometry, Aged, Radioisotopes, Chromogranin A/radiation effects [MeSH], Aged [MeSH], Organometallic Compounds/pharmacokinetics [MeSH], Radiometry [MeSH], Antineoplastic Agents/administration, Octreotide/administration, Original Article, Radioisotopes/administration, Male [MeSH], Radioisotopes/pharmacokinetics [MeSH], Neuroendocrine Tumors/radiotherapy [MeSH], Single Photon Emission Computed Tomography Computed Tomography [MeSH], Octreotide/analogs, Organometallic Compounds/administration, Female [MeSH], Octreotide/chemistry [MeSH], Radiopharmaceuticals/pharmacokinetics [MeSH], Humans [MeSH], Lutetium/pharmacokinetics [MeSH], Treatment Outcome [MeSH], Middle Aged [MeSH], Organometallic Compounds/pharmacology [MeSH], Lutetium/administration, Antineoplastic Agents/pharmacokinetics [MeSH], Radiopharmaceuticals/administration, Octreotide/pharmacokinetics [MeSH], Radiotherapy Dosage [MeSH], Monte Carlo Method [MeSH], Radiotherapy Dosage, Middle Aged, 3. Good health, Neuroendocrine Tumors, Treatment Outcome, Chromogranin A, Female, ddc:570, Radiopharmaceuticals, Monte Carlo Method
File Description: application/pdf
Access URL: https://link.springer.com/content/pdf/10.1007/s12149-020-01440-3.pdf
https://pubmed.ncbi.nlm.nih.gov/32114682
https://epub.uni-regensburg.de/50283/
https://pubmed.ncbi.nlm.nih.gov/32114682/
https://www.ncbi.nlm.nih.gov/pubmed/32114682
https://link.springer.com/content/pdf/10.1007/s12149-020-01440-3.pdf
https://link.springer.com/article/10.1007/s12149-020-01440-3
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101301
https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/23129
https://repository.publisso.de/resource/frl:6471498
https://epub.uni-regensburg.de/50283/ -
12
Authors: et al.
Source: Journal of Nuclear Medicine. 60:1259-1265
Subject Terms: Adult, Male, TRACERS, Receptors, Peptide, ENETS CONSENSUS GUIDELINES, DISEASE, Disease-Free Survival, Young Adult, 03 medical and health sciences, 0302 clinical medicine, CRITERIA, Humans, Aged, Proportional Hazards Models, METASTATIC NICHE, Aged, 80 and over, Data Collection, Interferon-alpha, Middle Aged, EFFICACY, 3. Good health, Neuroendocrine Tumors, multivariate analysis, Ki-67 Antigen, Treatment Outcome, Multivariate Analysis, TOLERABILITY, Chromogranin A, LU-177-OCTREOTATE, Female, PRRT, NEUROENDOCRINE TUMORS, neuroendocrine tumor, NEOPLASMS, Follow-Up Studies
Access URL: http://jnm.snmjournals.org/content/60/9/1259.full.pdf
https://pubmed.ncbi.nlm.nih.gov/30850483
https://jnm.snmjournals.org/content/60/9/1259
http://jnm.snmjournals.org/lookup/doi/10.2967/jnumed.118.224386
https://www.ncbi.nlm.nih.gov/pubmed/30850483
https://jnm.snmjournals.org/content/early/2019/02/28/jnumed.118.224386.full.pdf
https://pubmed.ncbi.nlm.nih.gov/30850483/
https://jnm.snmjournals.org/content/jnumed/60/9/1259.full.pdf -
13
Authors:
Source: Endocr Rev
Subject Terms: 0301 basic medicine, Neuroendocrine Tumors, 03 medical and health sciences, 0302 clinical medicine, PANCREATIC ENDOCRINE TUMORS, MIXED ADENONEUROENDOCRINE CARCINOMAS, ENETS CONSENSUS GUIDELINES, TUBEROUS SCLEROSIS GENE, GOBLET CELL CARCINOIDS, YIN-YANG 1, DNA METHYLATION, SMALL-BOWEL, HIGH-GRADE, SUPPRESSOR GENE, Reviews, Humans, Digestive System Neoplasms, Epigenesis, Genetic, 3. Good health
Access URL: https://pubmed.ncbi.nlm.nih.gov/30657883
https://pubmed.ncbi.nlm.nih.gov/30657883/
https://doi.org/10.1210/er.2018-00160
http://doi.org/10.1210/er.2018-00160
https://academic.oup.com/edrv/article/40/2/506/5289720
https://iris.univr.it/handle/11562/990365
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534496 -
14
Authors: et al.
Source: Levy, S, Verbeek, W H M, Eskens, F A L M, van den Berg, J G, de Groot, D J A, van Leerdam, M E & Tesselaar, M E T 2022, 'First-Line everolimus and cisplatin in patients with advanced extrapulmonary neuroendocrine carcinoma : a nationwide phase 2 single-arm clinical trial', Therapeutic advances in medical oncology, vol. 14, pp. 1–12. https://doi.org/10.1177/17588359221077088
Subject Terms: cisplatin, everolimus, neuroendocrine carcinoma, ENETS CONSENSUS GUIDELINES, GASTROINTESTINAL-TRACT, PROGNOSTIC-FACTORS, TUMORS, CHEMOTHERAPY, LUNG, ETOPOSIDE, THERAPY, CLASSIFICATION, RADIANT-4
File Description: application/pdf
Relation: info:eu-repo/semantics/altIdentifier/wos/000765780100001; info:eu-repo/semantics/altIdentifier/hdl/https://hdl.handle.net/11370/3cfc5199-5ce0-4252-809e-d877d82b29b4; info:eu-repo/semantics/altIdentifier/pissn/1758-8340
Availability: https://hdl.handle.net/11370/3cfc5199-5ce0-4252-809e-d877d82b29b4
https://research.rug.nl/en/publications/3cfc5199-5ce0-4252-809e-d877d82b29b4
https://doi.org/10.1177/17588359221077088
https://pure.rug.nl/ws/files/215525627/17588359221077088.pdf
https://www.scopus.com/pages/publications/85125848148 -
15
Authors: et al.
Subject Terms: Extrapulmonary neuroendocrine carcinoma, liver metastasis, platinum and etoposide, Enets Consensus Guidelines, Lung, Cancer, Tumors, G3
File Description: application/pdf
Relation: Northern Clinics of Istanbul; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; https://doi.org/10.14744/nci.2021.47887; https://hdl.handle.net/20.500.12831/8397; 35; 40; N/A; WOS:000795088200006; 522563
-
16
Authors: et al.
Contributors: et al.
Source: Int J Endocrinol
International Journal of Endocrinology, Vol 2018 (2018)Subject Terms: INTERNATIONAL STUDY-GROUP, ta3121, SURGICAL COMPLICATIONS, RC648-665, ENETS CONSENSUS GUIDELINES, General medicine, internal medicine and other clinical medicine, Diseases of the endocrine glands. Clinical endocrinology, 3. Good health, 03 medical and health sciences, POSITRON-EMISSION-TOMOGRAPHY, 0302 clinical medicine, ISGPS DEFINITION, SURGERY ISGPS, 13. Climate action, MANAGEMENT, FUNCTIONING INSULINOMA, PANCREATIC NEUROENDOCRINE TUMORS, NEOPLASMS, Research Article
File Description: text/xhtml; application/pdf
Access URL: https://downloads.hindawi.com/journals/ije/2018/2059481.pdf
https://pubmed.ncbi.nlm.nih.gov/30425741
https://doaj.org/article/bd23361b5b8040b39a0ae372dac907e2
https://pubmed.ncbi.nlm.nih.gov/30425741/
http://jultika.oulu.fi/Record/nbnfi-fe2019070122415
http://europepmc.org/articles/PMC6218736
https://trepo.tuni.fi/bitstream/10024/104639/1/characteristics%20and%20outcomes%202018.pdf
http://downloads.hindawi.com/journals/ije/2018/2059481.pdf
https://helda.helsinki.fi/handle/10138/262541
http://hdl.handle.net/10138/262541
http://urn.fi/urn:nbn:fi-fe2019070122415 -
17
Authors: et al.
Contributors: et al.
Source: The ENETS 2016 Munich Advisory Board Participants 2019, 'Unmet Medical Needs in Pulmonary Neuroendocrine (Carcinoid) Neoplasms', Neuroendocrinology, vol. 108, no. 1, pp. 7-17. https://doi.org/10.1159/000493980
Subject Terms: 0301 basic medicine, Biomedical Research, Lung Neoplasms, SOMATOSTATIN RECEPTORS, Carcinoid Tumor, ENETS 2016 Munich Advisory Board Participants, CHROMOGRANIN-A, ENETS CONSENSUS GUIDELINES, Endocrinology & Metabolism, 03 medical and health sciences, PROGNOSTIC-FACTORS, 0302 clinical medicine, Pulmonary carcinoids, Humans, EUROPEAN ASSOCIATION, PROLIFERATIVE INDEX, Science & Technology, Manchester Cancer Research Centre, CLINICAL-FEATURES, Neurosciences, 1103 Clinical Sciences, ECTOPIC ACTH SYNDROME, Prognosis, ResearchInstitutes_Networks_Beacons/mcrc, name=Manchester Cancer Research Centre, 3. Good health, NET, Bronchial carcinoid tumours, Neuroendocrine neoplasms, Neuroendocrine Tumors, EMC MM-01-39-01, CUSHINGS-SYNDROME, Neurosciences & Neurology, RECEPTOR RADIONUCLIDE THERAPY, 1109 Neurosciences, Life Sciences & Biomedicine
File Description: application/pdf
Access URL: https://repository.uantwerpen.be/docman/irua/9c6ee6/156743_2019_07_01.pdf
https://pubmed.ncbi.nlm.nih.gov/30248673
https://research.manchester.ac.uk/en/publications/eb03db80-3732-4cd7-a685-777c9939525e
https://doi.org/10.1159/000493980
https://pure.eur.nl/en/publications/cb310904-fa3e-402a-8fab-5183f9820101
https://doi.org/10.1159/000493980
http://uu.diva-portal.org/smash/record.jsf?pid=diva2:1284191
https://europepmc.org/article/MED/30248673
https://researchinformation.amsterdamumc.org/en/publications/unmet-medical-needs-in-pulmonary-neuroendocrine-carcinoid-neoplas
https://repub.eur.nl/pub/114778
http://www.diva-portal.org/smash/record.jsf?pid=diva2:1284191
http://spiral.imperial.ac.uk/bitstream/10044/1/64851/2/Umet%20needs%20in%20G3-%20enets-v%20311017.docx
https://www.karger.com/Article/Pdf/493980
https://doi.org/10.1159/000493980
https://hdl.handle.net/20.500.11768/90478
https://doi.org/10.1159/000493980
http://hdl.handle.net/10044/1/64851
https://pergamos.lib.uoa.gr/uoa/dl/object/2997959
https://hdl.handle.net/11380/1294883
https://doi.org/10.1159/000493980
https://hdl.handle.net/2318/1679072
https://doi.org/10.1159/000493980 -
18
Authors: et al.
Contributors: et al.
Source: Neuroendocrinology, Vol. 108, no. 1, p. 54-62 (2019)
Subject Terms: 0301 basic medicine, Biomedical Research, EMC OR-01, MULTICENTER, Neuroendocrine carcinoma, Neuroendocrine neoplasm, Neuroendocrine tumor, ENETS 2016 Munich Advisory Board Participants, ENETS CONSENSUS GUIDELINES, Endocrinology & Metabolism, 03 medical and health sciences, PROGNOSTIC-FACTORS, 0302 clinical medicine, MANAGEMENT, Humans, Gastrointestinal Neoplasms, Science & Technology, Neurosciences, 1103 Clinical Sciences, CHEMOTHERAPY, OPEN-LABEL, TUMORS, 3. Good health, Pancreatic Neoplasms, Neuroendocrine Tumors, SURGICAL-TREATMENT, CARCINOMAS, SURVIVAL, Neurosciences & Neurology, 1109 Neurosciences, Life Sciences & Biomedicine, Biomarkers
Access URL: https://repository.uantwerpen.be/docman/irua/c28a32/156748_2019_07_01.pdf
https://pubmed.ncbi.nlm.nih.gov/30153658
https://pure.eur.nl/en/publications/9829c482-4a33-4479-9c77-fef2fef22cbf
https://doi.org/10.1159/000493318
http://www.diva-portal.org/smash/record.jsf?pid=diva2:1284259
https://repub.eur.nl/pub/127175
https://pubmed.ncbi.nlm.nih.gov/30153658/
https://www.ncbi.nlm.nih.gov/pubmed/30153658
http://hdl.handle.net/10044/1/63914
https://hdl.handle.net/2078.1/224073
https://pergamos.lib.uoa.gr/uoa/dl/object/2997953 -
19
Authors: et al.
Source: Neuroendocrinology. 107:50-59
Subject Terms: Adult, Male, 0301 basic medicine, EUROPE, EMC OR-01, SMALL-CELL CARCINOMA, ENETS CONSENSUS GUIDELINES, Young Adult, 03 medical and health sciences, 0302 clinical medicine, SDG 3 - Good Health and Well-being, MANAGEMENT, Extra-pulmonary neuroendocrine carcinoma, Humans, Aged, Netherlands, Retrospective Studies, Aged, 80 and over, 2. Zero hunger, RARE CANCERS, Incidence, Population based study, Cancer registry, Middle Aged, 22/4 OA procedure, TUMORS, Survival Analysis, Carcinoma, Neuroendocrine, 3. Good health, UPDATE, Female, NEOPLASMS
Access URL: https://pubmed.ncbi.nlm.nih.gov/29945149
https://pure.eur.nl/en/publications/701e5c95-cfce-4f79-9a2c-728dfe95e5d7
https://doi.org/10.1159/000488987
https://hdl.handle.net/11370/82799499-8d74-42ae-9ace-c0ad2df441fb
https://doi.org/10.1159/000488987
https://research.rug.nl/en/publications/82799499-8d74-42ae-9ace-c0ad2df441fb
https://research.utwente.nl/en/publications/d039619d-74c6-43f8-af88-43bfabe5f684
https://doi.org/10.1159/000488987
https://www.rug.nl/research/portal/publications/extrapulmonary-neuroendocrine-carcinomas(82799499-8d74-42ae-9ace-c0ad2df441fb).html
https://pubmed.ncbi.nlm.nih.gov/29945149/
https://repub.eur.nl/pub/109258
http://www.ncbi.nlm.nih.gov/pubmed/29945149
https://europepmc.org/article/MED/29945149
https://research.rug.nl/en/publications/extra-pulmonary-neuroendocrine-carcinomas-a-population-based-stud -
20
Authors: et al.
Contributors: et al.
Subject Terms: hyperinsulinism, hypoglycaemia, insulin, insulinoma, neuroendocrine tumors, pancreas, quality of life, ENETS CONSENSUS GUIDELINES, SURGICAL COMPLICATIONS, PITUITARY-ADENOMAS, CLASSIFICATION, QUESTIONNAIRE, RECURRENCE, MANAGEMENT, SURGERY, General medicine, internal medicine and other clinical medicine
File Description: application/pdf
Relation: Helsinki University Hospital Research Funds, Grant/Award Number: TYH2019254; Medical Research Fund of Seinajoki Central Hospital, Grant/Award Number: 1717/6043 and 1717/6080; Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital, Grant/Award Number: 9U012 and 5900/3225; Finska Lakaresallskapet; http://hdl.handle.net/10138/325995; 000592403900001
Availability: http://hdl.handle.net/10138/325995
Full Text Finder
Nájsť tento článok vo Web of Science